Despite the controversy surrounding SHP2 mutations, other mutations identified in JMML, such as KRAS [28], NRAS [29, 30], and JAK3 [31, 32], have been shown to confer IL-3 independent growth on Ba/F3 cells. Here, KRAS is linked to juvenile myelomonocytic leukemia.